Back to calendar
AbCellera Biologics Inc. (ABCL) Earnings
ABCL reports earnings on Tuesday, November 10, 2026
earnings report
November 10, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.17
Actual EPS: $-0.18
EPS surprise: -9.76%
Company overview
Market Cap$3.7B
PriceUSD 11.35
EPS (TTM)-0.54
52-week high12.58
52-week low2.75
SectorHealth Technology
IndustryBiotechnology
Employees562